Plasminogen activator activity is decreased in rat gingiva during diabetes

Journal of Periodontology

Volumn 67, Issue 8, 1996, Pages 743-747

  Chang, Kuang Min ^a   Rani, Akula Shoba ^b   Chang, Kuang Chao ^c   Kumar, Surriender ^b  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Diabetes mellitus; Gingival diseases etiology; Plasminogen activators

Indexed keywords

COLLAGEN; COLLAGENASE; DOXYCYCLINE; ENZYME INHIBITOR; ENZYME PRECURSOR; GLUCOSE; PLASMIN; PLASMINOGEN ACTIVATOR; PROCOLLAGENASE; STREPTOZOCIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; GINGIVA; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; COLLAGEN; COLLAGENASES; DIABETES MELLITUS, EXPERIMENTAL; DOXYCYCLINE; ENZYME INHIBITORS; ENZYME PRECURSORS; GINGIVA; GLUCOSE; MALE; PLASMIN; PLASMINOGEN ACTIVATORS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030203884     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1996.67.8.743     Document Type: Article

References (53)

1. Schneir M, Bowerson J, Ramamurthy NS, et al. Response of rat connective tissue to streptozotocin-diabetes. Tissue specific effects on collagen metabolism. Biochim Biophys Acta 1979;583:95-102.
2. Schneir M, Ramamurthy NS, Golub LM. Extensive degradation of recently synthesized collagen in gingiva of normal and streptozotocin induced diabetic rats. J Dent Res 1984;63:23-27.
3. Golub LM, Garant PR, Ramamurthy NS. Inflammatory changes in gingival collagen in the alloxan-diabetic rat. J Perindont Res 1978;12:402-418.
4. Yu Z, Ramamurthy NS, Leung M, Chang KM, McNamara TF, Golub LM. Chemically-modified tetracycline normalizes collagen metabolism in diabetic rat: A dose-response study. J Periodont Res 1993;28:420-428.
5. Ramamurthy NS, Golub LM. Diabetes increases collagenase activity in extracts of rat gingiva and skin. J Periodont Res 1983;18:23-30.
6. Chang KM, Ramamurthy NS, McNamara TF, Genco RJ, Golub LM. Infection with a Gram-negative organism stimulates gingival collagenase production in non-diabetic and diabetic germ-free rats. J Periodont Res 1988;23:239-244.
7. Löe H. Periodontal disease, the sixth complication of diabetes mellitus. Diabetes Care 1993;16:329-334.
8. Shlossman M. Diabetes mellitus and periodontal disease - A current perspective. Compendium 1994;15:1018-1032.
9. Oliver RC, Tervonen T. Diabetes - A risk factor for periodontitis in adults? J Periodontol 1994;65:530-538.
10. Genco RJ. Assessment of risk of periodontal disease. Compendium 1994;(Suppl.)18:S678-683.
11. Birkedal-Hansen H. From tadpole collagenase to a family of matrix metalloproteinases. J Oral Pathol 1988;17:445-451.
12. Matrisian LH. Metalloproteinases and their inhibition in matrix remodeling. Trends Genet 1990;6:121-125.
13. Birkedal-Hansen H. Role of metalloproteinases in human periodontal diseases. J Periodontol 1993;64:474-484.
14. Murphy G, Ward R, Gavrilovic J, Atkinson S. Physiological mechanisms for metalloproteinase activation. Matrix 1991;(Suppl.)1:224-230.
15. Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagasi H. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochem 1990;29:10265-10270.
16. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 1992;667:1-12.
17. Mayer M. Biochemical and biological aspects of the plasminogen activation system. Clin Biochem 1990;23:197-211.
18. Cohen RL, Watanabe K, Schmid J, Chambers DA. Plasminogen activator in periodontal health and disease. Ann NY Acad Sci 1992;667: 183-185.
19. Cortellini P, Pini Prato G, Clauser C. Fibrinolytic activity of human gingiva in the presence or absence of plaque bacteria. J Periodont Res 1992;27:34-39.
20. Mochan E, Uhl J. Elevation in synovial fluid plasminogen activator in patients with rheumatoid arthritis. J Rheumatol 1984;11:123-128.
21. Inman RD, Harpel PCC. Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid. J Rheumatol 1986;13:535-537.
22. Martel-Pelletier J, Zafarullah M, Kodama S, Pelletier JP. In vitro effects of interleukin-1 on the synthesis of metalloproteinases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J Rheumatol 1991;18(Suppl.)27:80-84.
23. Hamsten A, Wiman B, DeFaire U, Blomback M. Increased plasma levels of rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985;313:1557-1563.
24. Almer L-O, Sundkvist G, Lilja B. Fibrinolytic activity, automatic neuropathy, and circulation in diabetes mellitus. Diabetes 1983;32(Suppl. 2):4-7.
25. Matsuo T, Kadowaki S, Okada K, Matsuo O. Activity of tissue plasminogen activator and plasminogen activator inhibitor in noninsulin dependent diabetes mellitus. J Diabetes Complications 1990;4:119-121.
26. Geiger M, Binder BR. Plasminogen activation in diabetes: Kinetics of plasmin formation with plasminogen and tissue plasminogen activator from diabetic donors. Sem Thromb Haemost 1991;17:417-421.
27. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS. A nonantimicrobial chemically modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987;66:1310-1314.
28. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans. J Periodont Res 1990;25:321-331.
29. Chang KM, Ryan ME, Golub LM, Ramamurthy NS, McNamara TE Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: effect of minocycline therapy. Res Commit Mol Pathol Pharmacol 1996;91:303-318.
30. Schroeder K, Lee H, Wolff M, Ramamurthy NS, Golub LM. Low-dose tetracyclines decrease elastase and β-glucuronidase activities in gingival crevicular fluid. J Dent Res 1990;69(Spec. Issue): 245(Abstr. 1090).
31. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Ann Biochem 1980;102:196-202.
32. Fuller JH, Keen H, Janett RJ, et al. Haemostatic variables associated with diabetes and its complications. Br Med J 1979;2:964-966.
33. Garcia Frade LJ, de la Calle H, Alava I, Navarro JL, Creighton LJ, Gaffney PJ. Diabetes mellitus as a hypercoagulable state. Its relationship with fibrin fragments and vascular damage. Thromb Res 1987;47:533-540.
34. Fisher BM, Quin JD, Rumley A, et al. Effects of acute insulin-induced hypoglycemia on haemostasis, fibrinolysis and haemorheology in insulin-dependent diabetic patients and control subjects. Clin Sci 1991;80:525-531.
35. Milwidsky A, Finci-Yeheskel Z, Mayer M. Direct inhibition of proteases and cervical plasminogen activator by antibiotics. Am J Obstel Gynecol 1992;166:606-612.
36. Kruithof EKO. Plasminogen activator inhibitors - A review. Enzyme 1988;40:113-121.
37. Collen D, Juhan-Vague I. Fibrinolysis and atherosclerosis. Sem Thromb Haemost 1988;14:180-183.
38. Van Wersch JWJ, Westerhuis LWJJM, Venekamp PWJR. Glycometabolic control and fibrinolysis in diabetic patients. Haemost 1990;20:241-250.
39. Geiger M, Binder BR. Plasminogen activation in diabetes mellitus. Kinetic analysis of plasmin formation using components isolated from the plasma of diabetic donors. J Biol Chem 1984;259:2976-2981.
40. Geiger M, Binder BR. Plasminogen activation in diabetes mellitus: normalization of blood sugar levels improves impaired enzyme kinetics in vitro. Thromb Haemost 1985;54:413-414.
41. Lawrence DAA, Loskutoff DJ. Inactivation of plasminogen activator inhibitor by oxidants. Biochem 1986;25:6351-6355.
42. Bagdade J, Root R, Bulger R. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974;23:9-15.
43. Bagdade J, Steward M, Walters E. Impaired granulocyte adherence: a reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978;27:677-681.
44. Golub LM, Lee HM, Lehrer G, et al. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodont Res 1983;18:516-526.
45. Sidhu MK, Kumar S. Synthesis and secretion of plasminogen activators and collagenases in human cells transformed by Kirsten murine sarcoma virus and N-Methyl-N′-nitro-N-nitrosoguanidine. Cancer Lett 1989;47:45-51.
46. Geiger M, Beckmann R, Binder BR. In: Progress in fibrinolysis. Davidson JF, Bachmann F, Bourier CAA, Kruithof EKO, eds. vol 6. Edinburgh: Churchill-Livingston; 1983:286-291.
47. Schmid J, Cohen RL, Chambers DA. Plasminogen activator in human periodontal health and disease. Arch Oral Biol; 1991;36:245-250.
48. Uitto V-J, Larjava H, Heino J, Sorsa T. A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect Immun 1989;57:213-218.
49. Mochan E, Armor L, Sporer R. Interleukin-1 stimulation of plasminogen activator production in cultured gingival fibroblasts. J Periodont Res 1988;23:28-32.
50. Kuraoka S, Campeau JD, Rodgers KE, Nakamura RM, DiZerega GS. Effects of interleukin-1 (IL-1) on postsurgical macrophage secretion of protease and protease inhibitors activities. J Surg Res 1992;52:71-78.
51. So T, Ito A, Sato T, Mori Y, Hirakawa SS. Tumor necrosis factor-α stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells. Biol Reproduc 1992;46:772-778.
52. Grills BL, Gallagher JA, Allen EEH, Yumita S, Martin TJ. Identification of plasminogen activator in osteoclasts. J Bone Min Res 1990;5:499-505.
53. Hoekman K, Löwik CWGM, Rint MVD, Bijvoet OLM, Verheijen JH, Papapoulos SE. The effect of tissue type plasminogen activator (tPA) on osteoclast resorption in embryonic mouse long bone explant: a possible role for the growth factor domain of tPA. Bone Min 1992;17:1-13.